Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Sleep and Breathing
Appendix
Available only for authorised users
Literature
1.
Latorre D, Kallweit U, Armentani E et al (2018) T cells in patients with narcolepsy target self-antigens of hypocretin neurons. Nature 562:63–68CrossRef
2.
Luo G, Ambati A, Lin L, Bonvalet M, Partinen M, Ji X, Maecker HT, Mignot EJ (2018) Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy. Proc Natl Acad Sci U S A 115:E12323–E12332CrossRef
3.
Lecendreux M, Berthier J, Corny J, Bourdon O, Dossier C, Delclaux C (2017) Intravenous immunoglobulin therapy in pediatric narcolepsy: a nonrandomized, open-label, controlled, longitudinal observational study. J Clin Sleep Med 13:441–453CrossRef
4.
Donjacour CEHM, Lammers GJ (2012) A remarkable effect of alemtuzumab in a patient suffering from narcolepsy with cataplexy. J Sleep Res 21:479–480CrossRef
5.
Kallweit U, Bassetti CLA, Oberholzer M, Fronczek R, Béguin M, Strub M, Lammers GJ (2018) Coexisting narcolepsy (with and without cataplexy) and multiple sclerosis : six new cases and a literature review. J Neurol 265:2071–2078CrossRef
Metadata
Title
Treatment with immune modulators in a child with recent-onset type 1 narcolepsy
Authors
Qidi Ding
Fulong Xiao
Xiaosong Dong
Jun Zhang
Fang Han
Publication date
01-03-2021
Publisher
Springer International Publishing
Published in
Sleep and Breathing / Issue 1/2021
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-020-02034-z

Other articles of this Issue 1/2021

Sleep and Breathing 1/2021 Go to the issue

Sleep Breathing Physiology and Disorders • Original Article

Serum adropin level is associated with endothelial dysfunction in patients with obstructive sleep apnea and hypopnea syndrome

Epidemiology • Letter to the Editors

Insomnia and type 2 diabetes mellitus: a risk assessment

Sleep Breathing Physiology and Disorders • Original Article

Practical and rapidly-implemented parameters for assessing APAP titration failure

Epidemiology • Short Communication

Perioperative myocardial injury risk after elective knee and hip arthroplasty in patients with a high risk of obstructive sleep apnea

Epidemiology • Original Article

Burn pit exposure in military personnel: is there an effect on sleep-disordered breathing?

ENT • Original Article

Translation and cultural adaptation of the Hebrew version of the Pediatric Sleep Questionnaire: a prospective, non-randomized control trial
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits